HIV-1 gp41 as a Target for Viral Entry Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|15|1805-1825

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.15, 2004-06, pp. : 1805-1825

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Membrane-Transferring Regions of gp41 as Targets for HIV-1 Fusion Inhibition and Viral Neutralization

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 2985-2996

Bentham Science Publishers

Access to resources Recommend Favorite

High Throughput Screening and Characterization of HIV-1 Entry Inhibitors Targeting gp41: Theories and Techniques

By  

Current Pharmaceutical Design, Vol. 10, Iss. 15, 2004-06 ,pp. : 1827-1843

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting HIV-1 gp41-induced Fusion and Pathogenesis for Anti-viral Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 2947-2958

Bentham Science Publishers

Access to resources Recommend Favorite

Biochemistry and Biophysics of HIV-1 gp41 - Membrane Interactions and Implications for HIV-1 Envelope Protein Mediated Viral-Cell Fusion and Fusion Inhibitor Design

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 2959-2984

Bentham Science Publishers

Access to resources Recommend Favorite

Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy

By  

Current Medicinal Chemistry, Vol. 20, Iss. 6, 2013-01 ,pp. : 751-771

Bentham Science Publishers

Access to resources Recommend Favorite